Rigel Pharmaceuticals, Inc. Insider Trading

RIGL

Last 12 months

Insiders sold 306K and bought nothing on the open market.

52% of the selling was scheduled in advance under 10b5-1 plans. Director Walter H Moos sold 145K on Feb 20, 24% of their stake, outside a plan. The last open-market buy by an executive or director was in Jun 2022.

Net open-market

−306K

0 buys · 3 sales

Under a 10b5-1 plan

52%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Jun 2022

Jun 9, 2022

Get an email when RIGL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 22	Kamil Ali-Jackson Director	Sold10b5-1 plan	2,500	$35.00	88K	20%	Form 4
May 26	Kamil Ali-Jackson Director	Sold10b5-1 plan	2,500	$29.17	73K	17%	Form 4
Feb 20	Walter H Moos Director	SoldNo plan	4,000	$36.36	145K	24%	Form 4
Feb 4, 2025 – Feb 5, 2025	Dean L Schorno EVP & Chief Financial Officer	SoldNo plan 2 parts	3,770	$21.38 average	81K	6.2%	Form 4
Feb 4, 2025 – Feb 5, 2025	David A Santos EVP, Chief Commercial Officer	SoldNo plan 2 parts	3,921	$21.38 average	84K	7.0%	Form 4
Feb 4, 2025 – Feb 5, 2025	Raul R Rodriguez CEO, President	SoldNo plan 2 parts	9,352	$21.40 average	200K	3.8%	Form 4
Feb 4, 2025 – Feb 5, 2025	Raymond J. Furey EVP, GC, CCO & Corp Sec	SoldNo plan 2 parts	2,787	$21.41 average	60K	6.7%	Form 4

Jun 2210b5-1 plan
Kamil Ali-Jackson
Director · sold 2,500 at $35.00
88K
20% of stake
May 2610b5-1 plan
Kamil Ali-Jackson
Director · sold 2,500 at $29.17
73K
17% of stake
Feb 20No plan
Walter H Moos
Director · sold 4,000 at $36.36
145K
24% of stake
Feb 4, 2025 – Feb 5, 2025No plan
Dean L Schorno
EVP & Chief Financial Officer · sold 3,770 at avg $21.38
81K
6.2% of stake
Feb 4, 2025 – Feb 5, 2025No plan
David A Santos
EVP, Chief Commercial Officer · sold 3,921 at avg $21.38
84K
7.0% of stake
Feb 4, 2025 – Feb 5, 2025No plan
Raul R Rodriguez
CEO, President · sold 9,352 at avg $21.40
200K
3.8% of stake
Feb 4, 2025 – Feb 5, 2025No plan
Raymond J. Furey
EVP, GC, CCO & Corp Sec · sold 2,787 at avg $21.41
60K
6.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch RIGL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with RIGL

CompareIntrinsic value

LGNDLigand Pharmaceuticals Inc.

$316.13+0.83%36

HROWHarrow Inc.

$28.75+0.74%46

LQDALiquidia Corporation

$47.38+12.27%72

AUPHAurinia Pharmaceuticals Inc.

$17.11+3.32%58

SDGRSchrodinger, Inc.

$28.52+4.93%36

SNDXSyndax Pharmaceuticals Inc.

$10.45-26.87%0

EOLSEvolus Inc.

$7.47+1.36%30

PHATPhathom Pharmaceuticals Inc.

$5.68-1.05%10

Held by ETFs

RIGL is in 44 US ETFs. The largest of them, with RIGL's weight in each:

Spot a number that looks wrong? Check it in RIGL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing RIGL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.